CompletedNot Applicable

Albumin, COP and Endothelial Damage in Patients With ESLD Undergoing OLT

50 participantsStarted 2015-12-06

Plain-language summary

To study the correlation between colloid osmotic pressure, albumin and the loss of vascular integrity in terms of endothelial dysfunction in patients with ESLD undergoing OLT and its impact on the perioperative course, as well as on morbidity and mortality.

Who can participate

Age range18 Years – 80 Years

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Child B/C Cirrhosis * patients, who undergo the first OLT Exclusion Criteria: * re-transplant * pregnancy * inoperability

What they're measuring

syndecan-1

Timeframe: 5 days

Trial details

NCT IDNCT03448679

SponsorMedical University of Vienna

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-12-06

View on ClinicalTrials.gov More Transplant-Related Disorder trials